203 related articles for article (PubMed ID: 24486643)
1. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
2. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.
Gramolelli S; Schulz TF
J Pathol; 2015 Jan; 235(2):368-80. PubMed ID: 25212381
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M
J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
[TBL] [Abstract][Full Text] [Related]
6. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
7. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
8. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
9. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.
Mutlu AD; Cavallin LE; Vincent L; Chiozzini C; Eroles P; Duran EM; Asgari Z; Hooper AT; La Perle KM; Hilsher C; Gao SJ; Dittmer DP; Rafii S; Mesri EA
Cancer Cell; 2007 Mar; 11(3):245-58. PubMed ID: 17349582
[TBL] [Abstract][Full Text] [Related]
10. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.
Yogev O; Lagos D; Enver T; Boshoff C
PLoS Pathog; 2014 Sep; 10(9):e1004400. PubMed ID: 25255370
[TBL] [Abstract][Full Text] [Related]
12. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming.
Cancian L; Hansen A; Boshoff C
Trends Cell Biol; 2013 Sep; 23(9):421-32. PubMed ID: 23685018
[TBL] [Abstract][Full Text] [Related]
13. Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.
DiMaio TA; Gutierrez KD; Lagunoff M
PLoS Pathog; 2011 Dec; 7(12):e1002424. PubMed ID: 22174684
[TBL] [Abstract][Full Text] [Related]
14. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
15. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
16. Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.
Lagunoff M
Curr Opin Virol; 2016 Aug; 19():45-9. PubMed ID: 27434732
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.
Lee HR; Li F; Choi UY; Yu HR; Aldrovandi GM; Feng P; Gao SJ; Hong YK; Jung JU
mBio; 2018 Jan; 9(1):. PubMed ID: 29339432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]